Mitral regurgitation is the most common form of valvular heart disease and affects around 10% of Americans over 75. It occurs when the mitral ...

Edwards Lifesciences has received CE marking for its transfemoral transcatheter mitral valve replacement system, setting up ...

The first-of-its-kind Edwards Lifesciences Sapien M3 TMVR system uses a nitinol dock to anchor the replacement valve in the patient's heart.

Edwards Lifesciences announced today that it received CE mark approval for its Sapien M3 mitral valve replacement system.

The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s ...

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as ...

The Cardiac Dimensions Carillon Mitral Contour System is a minimally invasive mitral regurgitation therapy made possible by ...

HighLife announced that it received FDA breakthrough device designation for its trans-septal mitral valve replacement (TMVR) ...

Edwards SAPIEN M3 mitral valve replacement system receives CE Mark for transcatheter treatment: Irvine, California Wednesday, ...

Edwards Lifesciences has received Europe’s CE mark for its transcatheter mitral valve replacement system, Sapien M3, the company said Monday. The device is designed for people with symptomatic ...